Cargando…
In silico identification of novel chemical compounds with antituberculosis activity for the inhibition of InhA and EthR proteins from Mycobacterium tuberculosis
Tuberculosis (TB) continuously poses a major public health concern around the globe, with a mounting death toll of approximately 1.4 million in 2019. Reduced bioavailability, elevated toxicity, increased side effects, and resistance of multiple first-line and second-line TB medications, including is...
Autores principales: | Halder, Sajal Kumar, Elma, Fatiha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173314/ https://www.ncbi.nlm.nih.gov/pubmed/34124395 http://dx.doi.org/10.1016/j.jctube.2021.100246 |
Ejemplares similares
-
In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis
por: Sulistyowaty, Melanny Ika, et al.
Publicado: (2023) -
Fragment-Based
Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020) -
Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
por: Xia, Yi, et al.
Publicado: (2018) -
Correction to Fragment-Based
Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020) -
InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
por: Flint, Lindsay, et al.
Publicado: (2020)